Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by MarketMoneyon Mar 18, 2021 5:28pm
240 Views
Post# 32829223

RE:RE:RE:I know why Aristotle is not released yet...Tripp is shorting

RE:RE:RE:I know why Aristotle is not released yet...Tripp is shorting

TrippingAgain2 wrote: Tripp is Elon lol. Worst comparison I have ever heard. They are complete opposites. I wonder who the pumpers are? If funny though Tripp states Arsitotle would be released Q1 and waits until the very last day of the quarter. Thats why the SP popped mid February for no reason since SZLS doesnt put out any material to help the shareholders that support them. (*potentially, Tripp has probably already made the calls and let his men know to pull out before the bad news comes) 

Why didnt Tripp just make it a Q2 release so it isn't so rushed and last minute. It literally MAKES NO SENSE to say Q1, and then wait until the VERY last day which is WAY more like a Q2 release.  SZLS ALWAYS looks so unprofessional and rushed and hurried for last minute eveything. It's embarassing and draws NO CONFIDENCE from shareholders as always.

This SP has only run on hype in it's lifetime and gets destoyed when reality kicks in. Every time. If you look at their complete history every time you see a spike up, IT HAS NEVER BEEN BY ANYTHING REAL, just speculation and false hype. Looks like it is happening agian, we shall see.

 

To have the maximum short interest position on SZLS I would also wait to release the news at the last minute. One reason I never all in on a stock is keep half position in cash to daytrade the moment we have a short squeeze, that's my most favorite part of daytrading, to burn any short seller recent positions and then pullback and let new short seller join and repeat again the same thing all over for as long as the weekly stage 2 stays, that's why I like weekly stage 2 :-) my longest intra daytrading was TECK.B for 5 years...imagine 5 years of shorts burning lol

Sorry if you invested during the weekly stage 1 during theses last years but why bashing the CEO when the charts was telling you not ready for liftoff???

Ichor blood is so efficient that SZLS are making money like never before! More cash and easier to market Aristotle. If you don't believe in Aristotle why are you still a shareholder? 

<< Previous
Bullboard Posts
Next >>